Schiff Counsels Altaris on its $1.55B Acquisition of Padagis

News

Schiff Counsels Altaris on its $1.55B Acquisition of Padagis

News Release |

Schiff advised Altaris Capital Partners, LLC on its acquisition of Padagis LLC, formerly the generic prescription pharmaceuticals business of Perrigo Company plc, for $1.55 billion. Padagis is a leader in the generic prescription pharmaceutical industry and has more than 1,300 employees across six locations in the United States and Israel. Altaris is an investment firm focused exclusively on the healthcare industry.